Syringes Market Size, Share, Trends, Industry Analysis Report
By Usage (Sterilizable/Reusable Syringes, Disposable Syringes, Prefilled Syringes), By Material, Application, By End User, and By Region – Market Forecast, 2025–2034
- Published Date:Sep-2025
- Pages: 125
- Format: PDF
- Report ID: PM6339
- Base Year: 2024
- Historical Data: 2020-2023
Overview
The global syringes market size was valued at USD 16.49 billion in 2024, growing at a CAGR of 8.53% from 2025 to 2034. Key factors driving demand for syringes include the increasing cases of diabetes worldwide coupled with rising government healthcare expenditure.
Key Insights
- The disposable syringes segment dominated the market share in 2024.
- The prefilled syringes segment is projected to grow at a rapid pace in the coming years, driven by demand for dosage accuracy, reduced risk of contamination, and patient convenience.
- The North America syringes market dominated the global market share in 2024.
- The U.S. syringes market is growing due to high adoption of advanced drug delivery devices and increasing healthcare expenditure.
- The market in Asia Pacific is projected to grow at a fast pace from 2025-2034, propelled by rising chronic disease cases and expanding pharmaceutical manufacturing.
- Countries such as China and Japan are playing a key role in regional growth, due to large-scale vaccination initiatives, advanced medical device manufacturing, and supportive healthcare policies.
Industry Dynamics
- Rising diabetic cases worldwide is fueling the market growth due to increasing need for insulin delivery and frequent self-administration of injections.
- Growing government healthcare spending worldwide drive the demand for syringes due to large-scale immunization campaigns, public health initiatives, and investments in modern healthcare infrastructure.
- The expansion of biologics and specialty drugs, is expected to create lucrative opportunities during the forecast period.
- The growing scrutiny over medical waste and single-use plastic syringes is anticipated to restrain market growth.
Market Statistics
- 2024 Market Size: USD 16.49 Billion
- 2034 Projected Market Size: USD 37.32 Billion
- CAGR (2025–2034): 8.53%
- North America: Largest Market Share
The syringes market encompasses a wide range of medical devices used for injecting or withdrawing fluids in healthcare practices. These instruments are essential in hospitals, clinics, diagnostic centers, and home healthcare for drug delivery, vaccination, blood sample collection, and therapeutic applications. Syringes are available in various types, including disposable, safety, and prefilled formats, designed to meet diverse clinical requirements while ensuring patient safety and infection control. The increasing prevalence of chronic diseases, rising vaccination programs, and expanding demand for self-administration devices are driving widespread adoption. Healthcare systems are prioritizing precision, safety, and efficiency, positioning syringes as a crucial component of modern medical delivery systems.
The increasing prevalence of chronic illnesses worldwide is fueling demand for syringes, as long-term treatments rely on regular injections, immunotherapies, and biologic drugs. A growing patient base requires reliable and safe drug delivery systems to manage conditions such as cancer and cardiovascular disorders. According to the U.S. Department of Health and Human Services, an estimated 129 million people in the U.S. live with at least one major chronic disease. Similarly, Eurostat’s 2023 data highlights that over 50.6% of Finland’s population and 43.2% of Germany’s population suffer from chronic health conditions. This substantial disease burden highlight the critical role of syringes in enabling effective treatment delivery, thereby driving global market expansion.
The rapid growth of the elderly population is elevating the demand for syringes, as older adults undergo a higher number of medical procedures, routine checkups, and preventive care treatments. Rising life expectancy is contributing to greater utilization of injectable therapies, vaccinations, and regular health monitoring, which are critical for maintaining quality of life in later years. Healthcare systems are adapting to this demographic shift by expanding medical services and care delivery, which in turn amplifies the global requirement for syringes.
Drivers & Opportunities
Increasing Diabetic Cases Worldwide: The global rise in the diabetic population is accelerating demand for syringes due to the increasing reliance on insulin therapy and other injectable treatments for effective disease management. The surging cases of diabetes worldwide is propelling healthcare systems to expand access to insulin delivery devices, ensuring consistent dosing accuracy and patient safety. According to the International Diabetes Federation, the global diabetic population is projected to reach 853 million by 2050, up from 589 million in 2024. This sharp increase is compelling healthcare providers to adopt advanced syringes and disposable variants, thereby firming up the growth outlook of the market across hospitals, clinics, and homecare settings.
Rising Government Healthcare Expenditure: The rising government healthcare spending is driving the growth of the syringes market, as investments in public health programs, vaccination campaigns, and hospital infrastructure continue to expand access to essential medical services. Increased allocation of funds enables healthcare systems to improve patient care, ensure a steady supply of medical devices, and adopt advanced injection technologies that enhance safety and efficiency. According to the World Health Organization (WHO), global health spending reached around USD 9 trillion in 2021. Moreover, government health spending in 2023 represented 10.1% of GDP in Germany and 9.5% in Japan. Thus, the scaling up of expenditures to address chronic disease management, boost immunization coverage, and prepare for future health emergencies, in turn amplifies demand for syringes across global markets.
Segmental Insights
Usage Analysis
Based on usage, the segmentation includes sterilizable/reusable syringes, disposable syringes, and prefilled syringes. The disposable syringes segment dominated the market in 2024, owing to its widespread adoption in hospitals and diagnostic centers for routine procedures and vaccination campaigns. The single-use design significantly reduces the risk of cross-contamination and hospital-acquired infections, making it the preferred choice in large-scale immunization programs. Additionally, government-led vaccination initiatives across developed and emerging countries continue to boost the demand for disposable syringes.
The prefilled syringes segment is projected to expand at the fastest pace during the forecast period, due to its growing role in biologics administration, oncology treatments, and chronic disease management such as diabetes that is hereby fueling adoption. Prefilled formats enhance dosage precision, reduce preparation errors, and improve patient convenience, in self-administration settings. For instance, in June 2025. W.L. Gore commercially launched its 0.5 mL silicone-free Gore ImProject syringe plunger, designed for prefilled syringes in ophthalmic and other sensitive applications. Additionally, increasing R&D in biologics and biosimilars, coupled with pharmaceutical companies’ preference for ready-to-use injectable formats is further fortifying the segment’s robust growth trajectory.
Material Analysis
In terms of material, the market is segmented into glass syringes and plastic syringes. Plastic syringes held the dominant share in 2024, driven by its cost-effectiveness, lightweight nature, and reduced breakage risks during handling and transportation. This versatility makes it suitable for single-use applications across vaccination drives and therapeutic injections, making it a staple in global healthcare systems. Moreover, the widespread manufacturing scalability also contributes to its sustained dominance.
The glass syringes segment is expected to grow steadily over the forecast period, driven by their compatibility with sensitive biologics, specialty injectables, and high-potency drugs. Glass maintains chemical stability and prevents interactions with complex formulations, making it the material of choice for biologics manufacturers. The rising pipeline of injectable biologics and increased regulatory emphasis on drug stability are key factors driving the expansion of this segment.
Application Analysis
By application, the market is segmented into vaccines and immunizations, anaphylaxis, diabetes, oncology, and others. The vaccines and immunizations segment led the market in 2024, driven by extensive global vaccination programs against infectious diseases, including booster campaigns for influenza. Mass immunization initiatives by organizations such as WHO and UNICEF, along with government procurement programs, continue to drive high-volume demand for syringes in this category.
The diabetes segment is anticipated to witness the fastest growth through 2034, attributed to the rising global prevalence of diabetes and the growing dependence on injectable insulin. Syringes play an important role in daily insulin administration, mainly in regions where insulin pens remain less accessible due to cost factors. Increasing awareness about early diagnosis and proactive disease management, alongside rising healthcare expenditure, is fueling demand for diabetes-focused syringes.
End User Analysis
Based on end user, the segmentation includes direct tenders, hospital pharmacies, retail pharmacies, and online pharmacies. Direct tenders accounted for the largest market share in 2024, as governments and healthcare institutions procure syringes in bulk to support national immunization and therapeutic programs. Centralized procurement strategies ensure cost efficiency and availability of large volumes in public health systems.
The online pharmacies segment is projected to register the fastest growth during the forecast period, due to the rapid expansion of e-commerce in healthcare, along with consumer preference for convenience and competitive pricing. Online platforms are making progress in emerging economies, where increasing internet penetration and home delivery services are transforming healthcare accessibility. The rise of chronic disease management kits and at-home care solutions is expected to further boost this channel’s market presence.
Regional Analysis
North America dominated the syringes market in 2024, driven by strong healthcare infrastructure and rising demand for advanced drug delivery systems. Continuous investment in vaccination programs, chronic disease management, and injectable therapies is fueling market growth across the region. The presence of major medical device manufacturers and a highly regulated healthcare framework further boost the development and distribution of technologically advanced syringes.
The U.S. Syringes Market Insights
The U.S. syringes market is driven by the rising cancer burden, as oncology treatments demand frequent and precise injectable delivery for chemotherapy, immunotherapy, and targeted biologics. The growing adoption of advanced therapeutics, such as monoclonal antibodies and CAR-T therapies, further boost the reliance on high-quality syringes for safe and accurate administration. According to the American Cancer Society, Inc., 2,041,910 new cancer cases are reported in 2025, with cancer-related deaths reaching 618,120 in the United States. This surge in cancer prevalence is pushing healthcare providers and pharmaceutical manufacturers to increase the use of syringes across hospitals, oncology clinics, and specialty centers to ensure effective patient care and treatment outcomes.
Europe Syringes Market Assessments
The market in Europe is projected to hold a substantial revenue share in 2034 due to established pharmaceutical manufacturing, rising prevalence of chronic conditions, and emphasis on patient safety in clinical practices. The region’s focus on preventive healthcare, combined with regulatory mandates for single-use and safety-engineered syringes, is driving consistent demand. Countries such as Germany, France, and Italy are witnessing high consumption across hospitals, diagnostic centers, and outpatient care facilities, ensuring sustained market expansion.
Asia Pacific Syringes Market Trends
Asia Pacific is anticipated to record the fastest growth during the forecast period, driven by wide adoption of safety syringes to minimize needle-stick injuries and rising vaccination initiatives across emerging economies. Growing government investment in public health programs, combined with expanding access to modern medical facilities, is accelerating syringe adoption across urban and rural areas. The region’s expanding pharmaceutical sector and large patient population are further driving demand for a wide range of syringes across therapeutic and preventive applications.
India Syringes Market Overview
India syringes industry is expanding due to the innovations in safety-engineered devices that address healthcare worker safety and infection control. The introduction of next-generation safety syringes minimizes the risk of accidental needle-stick injuries while meeting stringent regulatory requirements. For instance, in April 2024, Hindustan Syringes and Medical Devices (HMD) launched Dispojekt, an innovative safety needle syringe designed to reduce accidental needle-stick injuries and boost India’s presence in the global medical device market. Such product advancements enhance patient and provider safety along with expanding adoption across hospitals, clinics, and homecare settings, thereby fueling overall market growth.
Key Players & Competitive Analysis
The syringes market is highly competitive, with leading players such as Becton, Dickinson and Company (BD), Terumo Medical Corporation, Nipro Corporation, Gerresheimer AG, Schott AG, Cardinal Health, Inc., B. Braun SE, and Hindustan Syringes & Medical Devices Ltd. These companies focus on developing advanced syringe solutions, including prefilled syringes, safety syringes, and specialty syringes, to cater to applications in drug delivery, vaccination, and chronic disease management. The competitive dynamics are further shaped by launches and partnerships with pharmaceutical companies to secure large-scale production contracts. Increasing investment in automated manufacturing, needle-stick injury prevention technologies, and eco-friendly materials is reshaping the competitive landscape.
A few major companies operating in the Syringes industry include Becton, Dickinson and Company, Terumo Medical Corporation, Nipro Corporation, Gerresheimer AG, Schott AG, Cardinal Health, Inc., B. Braun SE, Hindustan Syringes & Medical Devices Ltd., Wuxi Yushou Medical Appliances Co., Ltd., Syntegon Technology GmbH, Sharps Technology, Inc., and Vita Needle Company.
Key Players
-
- B. Braun SE
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Gerresheimer AG
- Hindustan Syringes & Medical Devices Ltd.
- Nipro Corporation
- Schott AG
- Sharps Technology, Inc.
- Syntegon Technology GmbH
- Terumo Medical Corporation
- Vita Needle Company
- Wuxi Yushou Medical Appliances Co., Ltd.
Syringes Industry Developments
April 2025: Syntegon introduced the MLD Advanced, a state-of-the-art filling machine designed for ready-to-use (RTU) nested syringes that combines proven technologies from vial and cartridge lines. It delivers high output and ensure precise filling and weight verification for each syringe.
April 2025: Gerresheimer launched syringe systems made of glass and cyclic olefin polymer that are completely free of silicone oil and PFAS, offering a safer solution for sensitive biologics and applications including ophthalmology.
April 2024: BD launched the Neopak XtraFlow glass prefillable syringe to better serve the growing biologics market and expanded its production capacity. The new syringe features an 8mm needle and thinner wall cannula, enhancing the delivery of higher viscosity drugs by reducing injection force and time.
Syringes Market Segmentation
By Usage Outlook (Revenue, USD Billion, 2020–2034)
- Sterilizable/Reusable Syringes
- Hypodermic Syringes
- Oral Syringes
- Disposable Syringes
- Conventional Syringes
- Safety Syringes
- Retractable Safety Syringes
- Non-Retractable Safety Syringes
- Prefilled Syringes
By Material Outlook (Revenue, USD Billion, 2020–2034)
- Glass Syringes
- Plastic Syringes
By Application Outlook (Revenue, USD Billion, 2020–2034)
- Vaccines and Immunizations
- Anaphylaxis
- Diabetes
- Oncology
- Others
By End User Outlook (Revenue, USD Billion, 2020–2034)
- Direct Tenders
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Outlook (Revenue, USD Billion, 2020–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Syringes Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 16.49 Billion |
|
Market Size in 2025 |
USD 17.87 Billion |
|
Revenue Forecast by 2034 |
USD 37.32 Billion |
|
CAGR |
8.53% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD Billion and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
© 2025 Polaris Market Research and Consulting. All rights reserved
